Abstract
The involvement of potassium channels in the venodilating capacity of the inodilator levosimendan in human saphenous vein preparations was investigated. Levosimendan caused relaxation with 50% effective concentration (EC 50) of 0.32±0.04 μM in isolated veins contracted by 5-hydroxytryptamine. Fifteen μM glibenclamide, a blocker of the ATP-sensitive potassium channels (KATP), partially inhibited the relaxing effect of the inodilator. In the presence of iberiotoxin, the selective blocker of large conductance calcium-activated potassium channels (BKCa), levosimendan induced contraction with EC50 of 0.21±0.06 μM. We presume that levosimendan dilates human saphenous veins by interacting with hyperpolarizing potassium channels (KATP and BKCa).
Cite
CITATION STYLE
Höhn, J., Pataricza, J., Petri, A., Tóth, G. K., Balogh, Á., Varró, A., & Papp, J. G. (2004). Levosimendan interacts with potassium channel blockers in human saphenous veins. Basic and Clinical Pharmacology and Toxicology, 94(6), 271–273. https://doi.org/10.1111/j.1742-7843.2004.pto940603.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
